AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

CRON vs TLRY: stock comparison and AI forecast

Cronos Group Inc. (CRON) and Tilray Brands, Inc. (TLRY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Medicinal Chemicals & Botanical Products

CRON Cronos Group Inc.

Market Cap
$1.37B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Medicinal Chemicals & Botanical Products

TLRY Tilray Brands, Inc.

Market Cap
$415M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CRON · TLRY

Key facts

  • CRON is 3.3 times larger than TLRY by market capitalization ($1.37B against $415M).
  • TLRY carries 0.44 times debt per unit of equity, against 0.07 times for CRON.
  • Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCRONTLRY
Market Cap$1.37B$415M
P/B Ratio1.28x0.26x
EPS$-0.05$-1.41
Book Value/Share$2.91$10.98
Revenue/Share$0.74$6.52
FCF/Share$0.18–

Profitability & Margins

MetricCRONTLRY
ROE–-10.1%
ROA–-7.0%
ROIC0.6%-4.7%
Gross Margin35.3%29.1%
Operating Margin2.6%-9.3%
Net Margin–-17.1%
EBT Margin22.1%-13.0%
Tax Rate-14.2%-16.8%

Financial Health

MetricCRONTLRY
Current Ratio12.71x1.88x
Quick Ratio11.91x1.11x
D/E Ratio0.07x0.44x
Financial Leverage1.12x1.43x
Interest Coverage42.0x-0.6x
Working Capital$792M$377M

Cash Flow

MetricCRONTLRY
Operating Cash Flow$81M-$84M
Free Cash Flow$65M–
Capital Spending-$16M–
OCF Growth YoY272.8%–
FCF/Sales24.1%–
CapEx/Sales5.8%–

Operational Efficiency

MetricCRONTLRY
Asset Turnover0.23x0.41x
Receivables Turnover6.2x5.0x
Inventory Turnover–2.1x
Fixed Assets Turnover1.9x1.4x
Days Sales Outstanding59 days72 days
Days Inventory–176 days
Payables Period–71 days
Cash Conversion Cycle–177 days

Income Statement

MetricCRONTLRY
Total Revenue$272M$963M
Operating Income$7M-$89M
Net Income–-$164M
R&D Expense$5M$410K
SG&A Expense$85M$270M
Cost of Goods Sold–$683M

Dividend & Shareholder Information

MetricCRONTLRY
Shares Outstanding368M148M
EPS Growth-131.2%–
FAQ

CRON vs TLRY: stock comparison and AI forecast

Which is bigger, CRON or TLRY?

CRON is 3.3 times larger than TLRY by market capitalization ($1.37B against $415M).

Which one does Intratio's AI model rank higher, CRON or TLRY?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.